NTLA - Intellia Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.29
DETAILS
HIGH:
$49.00
LOW:
$13.00
MEDIAN:
$25.00
CONSENSUS:
$26.29
UPSIDE:
108.65%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 76.5% |
| EBIT Margin | -609.9% |
| EBITDA Margin | -586.3% |
| Operating Margin | -651.7% |
| Pretax Margin | -609.9% |
| Cont. Ops Margin | -609.9% |
| Net Margin | -609.9% |
| Bottom Line Margin | -609.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.08 |
| Quick Ratio | 5.08 |
| Solvency Ratio | -2.324 |
| Cash Ratio | 1.50 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-2.36
Peers avg: 19.1
|
| PEG Ratio | 0.09 |
| Forward PEG | 0.09 |
| Price/Book | 1.45 |
| Price/Sales | 14.40 |
| Price/FCF | -2.75 |
| Price/Op Cash Flow | -2.79 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1108 |
| Debt/Equity | 0.1390 |
| Debt/Capital | 0.1220 |
| Long-Term Debt/Capital | 0.0906 |
| Financial Leverage | 1.25 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.14 |
| Operating Cash Flow Ratio | -3.358 |
| Operating Cash Flow/Sales | -515.6% |
| Free Cash Flow/Operating Cash Flow | 101.7% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -14.98 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -13.18 |
| Operating Cash Flow Coverage | -3.74 |
| Capital Expenditure Coverage | -60.38 |
| Dividend + Capital Expenditure Coverage | -60.38 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.62 |
| EPS | -3.808 |
| Debt/Share | 0.8612 |
| Cash/Share | 4.15 |
| Book Value/Share | 6.20 |
| Tangible BV/Share | 6.20 |
| Equity/Share | 6.20 |
| Operating Cash Flow/Share | -3.219 |
| Capital Expenditure/Share | 0.053 |
| FCF/Share | -3.272 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.936 |
| Price/Fair Value | 1.45 |
| Debt/Market Cap | 0.0958 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -2.30 |